{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:03:55Z","timestamp":1791353035992,"version":"4.3.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01 NS42888"],"award-info":[{"award-number":["R01 NS42888"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01 NS54962"],"award-info":[{"award-number":["R01 NS54962"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R21NS087467"],"award-info":[{"award-number":["R21NS087467"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.expneurol.2016.05.020","type":"journal-article","created":{"date-parts":[[2016,5,18]],"date-time":"2016-05-18T20:48:45Z","timestamp":1463604525000},"page":"49-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Sialylated intravenous immunoglobulin suppress anti-ganglioside antibody mediated nerve injury"],"prefix":"10.1016","volume":"282","author":[{"given":"Gang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia A.","family":"Massaad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila","family":"Pillai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nataliia","family":"Bogdanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameera","family":"Ghauri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazim A.","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2016.05.020_bb0005","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1126\/science.1154315","article-title":"Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc","volume":"320","author":"Anthony","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2016.05.020_bb0010","doi-asserted-by":"crossref","first-page":"19571","DOI":"10.1073\/pnas.0810163105","article-title":"Identification of a receptor required for the anti-inflammatory activity of IVIG","volume":"105","author":"Anthony","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2016.05.020_bb0015","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature10134","article-title":"Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway","volume":"475","author":"Anthony","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2016.05.020_bb0020","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1749-6632.2011.06305.x","article-title":"Novel roles for the IgG Fc glycan","volume":"1253","author":"Anthony","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2016.05.020_bb0025","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1146\/annurev.immunol.25.022106.141702","article-title":"The impact of glycosylation on the biological function and structure of human immunoglobulins","volume":"25","author":"Arnold","year":"2007","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.expneurol.2016.05.020_bb0030","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00005792-196905000-00001","article-title":"The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis","volume":"48","author":"Asbury","year":"1969","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.expneurol.2016.05.020_bb0035","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/ncpneuro0429","article-title":"Shortage of human intravenous immunoglobulin\u2013reasons and possible solutions","volume":"3","author":"Bayry","year":"2007","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"10.1016\/j.expneurol.2016.05.020_bb0040","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrneurol.2011.121","article-title":"Advances in the diagnosis, pathogenesis and treatment of CIDP","volume":"7","author":"Dalakas","year":"2011","journal-title":"Nat. Rev. Neurol."},{"issue":"Suppl.","key":"10.1016\/j.expneurol.2016.05.020_bb0045","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1002\/ana.410270717","article-title":"Macrophage responses in inflammatory demyelinating neuropathies","volume":"27","author":"Griffin","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2016.05.020_bb0050","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ana.410400414","article-title":"Acute motor axonal neuropathy: an antibody-mediated attack on axolemma","volume":"40","author":"Hafer-Macko","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2016.05.020_bb0055","doi-asserted-by":"crossref","first-page":"6770","DOI":"10.1523\/JNEUROSCI.4926-14.2015","article-title":"Anti-ganglioside antibodies induce nodal and axonal injury via Fcgamma receptor-mediated inflammation","volume":"35","author":"He","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2016.05.020_bb0060","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/S0952-7915(02)00409-0","article-title":"Fc receptors are major mediators of antibody based inflammation in autoimmunity","volume":"14","author":"Hogarth","year":"2002","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.expneurol.2016.05.020_bb0065","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","article-title":"Guillain-Barr\u00e9 syndrome","volume":"366","author":"Hughes","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2016.05.020_bb0070","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0165-5728(99)00195-2","article-title":"Pathogenesis of Guillain-Barr\u00e9 syndrome","volume":"100","author":"Hughes","year":"1999","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2016.05.020_bb0075","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/ana.410230503","article-title":"Serum antibodies to gangliosides in Guillain-Barr\u00e9 syndrome","volume":"23","author":"Ilyas","year":"1988","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2016.05.020_bb0080","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1126\/science.1129594","article-title":"Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation","volume":"313","author":"Kaneko","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2016.05.020_bb0085","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1006\/jaut.1999.0302","article-title":"In vivo administration of intravenous immunoglobulin (IVIg) can lead to enhanced erythrocyte sequestration","volume":"13","author":"Kessary-Shoham","year":"1999","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.expneurol.2016.05.020_bb0090","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0301-0082(00)00060-5","article-title":"The role of macrophages in immune-mediated damage to the peripheral nervous system","volume":"64","author":"Kiefer","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.expneurol.2016.05.020_bb0095","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1523\/JNEUROSCI.4017-06.2007","article-title":"Passive immunization with anti-ganglioside antibodies directly inhibits axon regeneration in an animal model","volume":"27","author":"Lehmann","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2016.05.020_bb0100","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1046\/j.1471-4159.2000.0750404.x","article-title":"High-affinity anti-ganglioside IgG antibodies raised in complex ganglioside knockout mice: reexamination of GD1a immunolocalization","volume":"75","author":"Lunn","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2016.05.020_bb0105","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/ana.410330402","article-title":"Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China","volume":"33","author":"McKhann","year":"1993","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2016.05.020_bb0110","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1212\/NXI.0000000000000050","article-title":"Occurrence of hemolytic anemia in patients with GBS treated with high-dose IVIg","volume":"1","author":"Nguyen","year":"2014","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"},{"key":"10.1016\/j.expneurol.2016.05.020_bb0115","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri2206","article-title":"Fcgamma receptors as regulators of immune responses","volume":"8","author":"Nimmerjahn","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.expneurol.2016.05.020_bb0120","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/1531-8249(200010)48:4<624::AID-ANA9>3.0.CO;2-O","article-title":"Axonal Guillain-Barr\u00e9 syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan","volume":"48","author":"Ogawara","year":"2000","journal-title":"Ann. Neurol."},{"issue":"Suppl.","key":"10.1016\/j.expneurol.2016.05.020_bb0125","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/ana.410090704","article-title":"Pathology of the Guillain-Barr\u00e9 syndrome","volume":"9","author":"Prineas","year":"1981","journal-title":"Ann. Neurol."},{"issue":"Suppl.","key":"10.1016\/j.expneurol.2016.05.020_bb0130","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1002\/ana.410270713","article-title":"Antibodies to gangliosides and myelin proteins in Guillain-Barr\u00e9 syndrome","volume":"27","author":"Quarles","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2016.05.020_bb0135","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1126\/science.291.5503.484","article-title":"Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor","volume":"291","author":"Samuelsson","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2016.05.020_bb0140","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1006\/abio.2001.5540","article-title":"IgG-class mouse monoclonal antibodies to major brain gangliosides","volume":"302","author":"Schnaar","year":"2002","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.expneurol.2016.05.020_bb0145","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/nri3401","article-title":"Intravenous immunoglobulin therapy: how does IgG modulate the immune system?","volume":"13","author":"Schwab","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.expneurol.2016.05.020_bb0150","doi-asserted-by":"crossref","first-page":"4788","DOI":"10.1073\/pnas.0807319106","article-title":"Impaired inhibitory Fcgamma receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy","volume":"106","author":"Tackenberg","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Suppl. 1","key":"10.1016\/j.expneurol.2016.05.020_bb0155","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1007\/s10875-010-9398-1","article-title":"Mechanisms of IVIG efficacy in chronic inflammatory demyelinating polyneuropathy","volume":"30","author":"Tackenberg","year":"2010","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.expneurol.2016.05.020_bb0160","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/nri856","article-title":"Roles of Fc receptors in autoimmunity","volume":"2","author":"Takai","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.expneurol.2016.05.020_bb0165","doi-asserted-by":"crossref","first-page":"E1297","DOI":"10.1073\/pnas.1422481112","article-title":"Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity","volume":"112","author":"Washburn","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2016.05.020_bb0170","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1093\/brain\/awf272","article-title":"Peripheral neuropathies and anti-glycolipid antibodies","volume":"125","author":"Willison","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2016.05.020_bb0175","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMra1114525","article-title":"Guillain-Barr\u00e9 syndrome","volume":"366","author":"Yuki","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2016.05.020_bb0180","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/ana.1012","article-title":"Animal model of axonal Guillain-Barr\u00e9 syndrome induced by sensitization with GM1 ganglioside","volume":"49","author":"Yuki","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2016.05.020_bb0185","doi-asserted-by":"crossref","first-page":"11404","DOI":"10.1073\/pnas.0402391101","article-title":"Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barr\u00e9 syndrome","volume":"101","author":"Yuki","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2016.05.020_bb0190","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/brain\/awh127","article-title":"Anti-ganglioside antibody-mediated neuronal cytotoxicity and its protection by intravenous immunoglobulin: implications for immune neuropathies","volume":"127","author":"Zhang","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2016.05.020_bb0195","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1523\/JNEUROSCI.3829-10.2011","article-title":"Anti-ganglioside antibody-mediated activation of RhoA induces inhibition of neurite outgrowth","volume":"31","author":"Zhang","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2016.05.020_bb0200","doi-asserted-by":"crossref","first-page":"e88703","DOI":"10.1371\/journal.pone.0088703","article-title":"Fcgamma receptor-mediated inflammation inhibits axon regeneration","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS One"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488616301388?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488616301388?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T16:53:31Z","timestamp":1567875211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488616301388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":40,"alternative-id":["S0014488616301388"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2016.05.020","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sialylated intravenous immunoglobulin suppress anti-ganglioside antibody mediated nerve injury","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2016.05.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}